Central fatigue and neurotransmitters, can thermoregulation be manipulated?

Scandinavian Journal of Medicine and Science in Sports

Volumn 20, Issue SUPPL. 3, 2010, Pages 19-28

  Meeusen, R ^a   Roelands, B ^a  

^a VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

Author keywords

Central fatigue; Exercise performance; Heat; Pharmacological manipulation

Indexed keywords

AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; DOPAMINE; NORADRENALIN; SEROTONIN;

EXERCISE TOLERANCE; FATIGUE; HEAT; HUMAN; PATHOLOGY; REVIEW; RISK FACTOR; TASK PERFORMANCE; THERMOREGULATION; TIME;

BODY TEMPERATURE REGULATION; DOPAMINE; EXERCISE TOLERANCE; FATIGUE; HOT TEMPERATURE; HUMANS; NEUROTRANSMITTER AGENTS; NOREPINEPHRINE; RISK FACTORS; SEROTONIN; TASK PERFORMANCE AND ANALYSIS; TIME FACTORS;

EID: 77957340232     PISSN: 09057188     EISSN: 16000838     Source Type: Journal    
DOI: 10.1111/j.1600-0838.2010.01205.x     Document Type: Review

References (92)

1. Ascher JA, Cole JO, Colin JN. Bupropion: a review of its mechanism and antidepressant activity. J Clin Psychiatry 1995, 56((9)):395-401.
2. Bailey SP, Davis JM, Ahlborn EN. Neuroendocrine and substrate responses to altered brain 5-HT activity during prolonged exercise to fatigue. J Appl Physiol 1993, 74((6)):3006-3012.
3. Bergstrom J, Hermansen L. Diet, muscle glycogen and physical performance. Acta Physiol Scand 1967, 71((2)):140-150.
4. Borg G, Edstrom CG, Linderholm H. Changes in physical performance induced by amphetamine and amobarbital. Psychopharmacologia 1972, 26((1)):10-18.
5. Boulant JA. The effect of firing rate on preoptic neuronal thermosensitivity. J Physiol 1974, 240(3):661-9.
6. Boulant JA, Dean JB. Temperature receptors in the central nervous system. Annu Rev Physiol 1986, 48:639-654.
7. Bridge MW, Weller AS, Rayson M. Responses to exercise in the heat related to measures of hypothalamic serotonergic and dopaminergic function. Eur J Appl Physiol 2003, 89((5)):451-459.
8. Brown SJ, Gisolfi CV, Mora F. Temperature regulation and dopaminergic systems in the brain: does the substantia nigra play a role? Brain Res 1982, 234:275-286.
9. Brück K, Olschewski H. Body temperature related factors diminishing the drive to exercise. Can J Sports Sci 1987, 65:1274-1280.
10. Burgess ML, Davis JM, Borg TK, Buggy J. Intracranial self-stimulation motivates treadmill running in rats. J Appl Physiol 1991, 71((4)):1593-1597.
11. Byrne C, Lee JK, Chew SA. Continuous thermoregulatory response to mass-participation distance running in heat. Med Sci Sports Exerc 2006, 38:803-810.
12. Chaouloff F, Kennett GA, Serrurrier B. Amino acid analysis demonstrates that increased plasma free tryptophan causes the increase of brain tryptophan during exercise in the rat. J Neurochem 1986, 46((5)):1647-1650.
13. Cheung SS. Hyperthermia and voluntary exhaustion: integrating models and future challenges. Appl Physiol Nutr Metab 2007, 32:808-817.
14. Cheung SS, McLellan MT. Heat acclimation, aerobic fitness, and hydration effects on tolerance during uncompensable heat stress. J Appl Physiol 1998, 84((5)):1731-1739.
15. Clark WG, Lipton JM. Changes in body temperature after administration of adrenergic and serotonergic agents and related drugs including antidepressants: II. Neurosci Biobehav Rev 1986, 10:153-220.
16. Davis JM, Bailey SP. Possible mechanisms of central nervous system fatigue during exercise. Med Sci Sports Exerc 1997, 29((1)):45-57.
17. Davis JM, Bailey SP, Jackson DA. Effects of a serotonin (5-HT) agonist during prolonged exercise to fatigue in humans. Med Sci Sports Exerc 1993, 25:S78.
18. Del Arco A, Mora F. Neurotransmitters and prefrontal cortex-limbic system interactions: implications for plasticity and psychiatric disorders. J Neural Transm 2009, 116:941-952.
19. Ely BR, Ely MR, Cheuvront SN. Evidence against a 40 degrees C core temperature threshold for fatigue in humans. J Appl Physiol 2009, 107((5)):1519-1525.
20. Feldberg W, Myers RD. A new concept of temperature regulation by amines in the hypothalamus. Nature 1963, 28:1325.
21. Foley T, Fleshner M. Neuroplasticity of dopamine circuits after exercise: implications for central fatigue. Neuromol Med 2008, 10:67-80.
22. Fuller A, Carter RN, Mitchell D. Brain and abdominal temperatures at fatigue in rats exercising in the heat. J Appl Physiol 1998, 84:877-883.
23. Galloway SD, Maughan RJ. Effects of ambient temperature on the capacity to perform prolonged cycle exercise in man. Med Sci Sports Exerc 1997, 29((9)):1240-1249.
24. Gerald MC. Effects of (+)-amphetamine on the treadmill endurance performance of rats. Neuropharmacology 1978, 17((9)):703-704.
25. Gisolfi C, Christman J. Thermal effects of injecting norepinephrine into hypothalamus of the rat during rest and exercise. J Appl Physiol 1980, 49:937-941.
26. González-Alonso J, Calbet J. Reductions in systemic and skeletal muscle blood flow and oxygen delivery limit maximal aerobic capacity in humans. Circulation 2003, 107:824-830.
27. Gonzalez-Alonso J, Calbet JA, Nielsen B. Metabolic and thermodynamic responses to hydration-induced reductions in muscle blood flow in exercising humans. J Physiol 1999a, 520:577-589.
28. Gonzalez-Alonso J, Teller C, Andersen SL, Jensen FB, Hyldig T, Nielsen B. Influence of body temperature on the development of fatigue during prolonged exercise in the heat. J Appl Physiol 1999b, 86((3)):1032-1039.
29. Hargreaves M, Febbraio M. Limits to exercise performance in the heat. Int J Sports Med 1998, 19((2)):S115-S116.
30. Hasegawa H, Ishiwata T, Saito T. Inhibition of the preoptic area and anterior hypothalamus by tetrodotoxin alters thermoregulatory functions in exercising rats. J Appl Physiol 2005, 98((4)):1458-1462.
31. Hasegawa H, Piacentini MF, Sarre S. Influence of brain catecholamines on the development of fatigue in exercising rats in the heat. J Physiol 2008, 586((1)):141-149.
32. Havel RJ, Pernow B, Jones NL. Uptake and release of free fatty acids and other metabolites in the legs of exercising men. J Appl Physiol 1967, 23((1)):90-99.
33. Heyes MP, Garnett ES, Coates G. Central dopaminergic activity influences rats ability to exercise. Life Sci 1985, 36((7)):671-677.
34. Ishiwata T, Saito T, Hasegawa H, Yazawa T, Otokawa M, Aihara Y. Changes of body temperature and extracellular serotonin level in the preoptic area and anterior hypothalamus after thermal or serotonergic pharmacological stimulation of freely moving rats. Life Sci 2004, 75:2665-2675.
35. Jacobs I, Bell DG. Effects of acute modafinil ingestion on exercise time to exhaustion. Med Sci Sports Exerc 2004, 36((6)):1078-1082.
36. Jefferson JW, Pradko JF, Muir KT. Bupropion for major depressive disorder: pharmacokinetic and formulation considerations. Clin Therapeut 2005, 27((11)):1685-1695.
37. Lin M, Tsay H, Su W. Changes in extracellular serotonin in rat hypothalamus affect thermoregulatory function. 1998, 274((5, Part 2)):R1260-R1267.
38. MacDougall JD, Reddan WG, Layton CR. Effects of metabolic hyperthermia on performance during heavy prolonged exercise. J Appl Physiol 1974, 36:538-544.
39. Marino FE. Anticipatory regulation and avoidance of catastrophe during exercise-induced hyperthermia. Comp Biochem Physiol B Biochem Mol Biol 2004, 139((4)):535-538.
40. Marino FE, Lambert MI, Noakes TD. Superior performance of African runners in warm humid but not in cool environmental conditions. J Appl Physiol 2004, 96((1)):124-130.
41. Marvin G, Sharma A, Aston W. The effects of buspirone on perceived exertion and time to fatigue in man. Exp Physiol 1997, 82((6)):1057-1060.
42. Meeusen R, Roeykens J, Magnus L. Endurance performance in humans: the effect of a dopamine precursor or a specific serotonin (5-HT2A/2C) antagonist. Int J Sports Med 1997, 18((8)):571-577.
43. Meeusen R, Piacentini MF, Van Den Eynde S. Exercise performance is not influenced by a 5-HT reuptake inhibitor. Int J Sports Med 2001, 22((5)):329-336.
44. Meeusen R, Watson P, Dvorak J. The brain and fatigue: new opportunities for nutritional interventions? J Sports Sci 2006a, 24:773-782.
45. Meeusen R, Watson P, Hasegawa, et al. Central fatigue. The serotonin hypothesis and beyond. Sports Med 2006b, 36((10)):881-909.
46. Meeusen R, De Meirleir K. Exercise and Brain neurotransmission. Sports Med 1995, 20((3)):160-188.
47. Montgomery S. Reboxetine: additional benefits to the depressed patient. J Psychopharmacol 1997, 11:S9-S15.
48. Morrison SA, Sleivert GG, Cheung SS. Passive hyperthermia reduces voluntary activation and isometric force production. Eur J Appl Physiol 2004, 91:729-736.
49. Myers R, Beleslin D, Rezvani A. Hypothermia: role of alpha 1- and alpha 2-noradrenergic receptors in the hypothalamus of the cat. Pharmacol Biochem Behav 1987, 26:373-379.
50. Myers RD, Yaksh TL. Feeding and temperature responses in the unrestrained rat after injections of cholinergic and aminergic substances into the cerebral ventricles. Physiol Behav 1968, 3:917-928.
51. Nakayama T, Eisenman JS, Hardy JD. Single unit activity of anterior hypothalamus during local heating. Science 1961, 134:560-561.
52. Newsholme EA, Acworth I, Blomstrand E. Amino acids, brain neurotransmitters and a function link between muscle and brain that is important in sustained exercise. Advances in myochemistry 1987, 127-133. Benzi G, ed, London, John Libbey Eurotext
53. Ng QY, Lee KW, Byrne C. Plasma endotoxin and immune responses during a 21 km road race under a warm and humid environment. Ann Acad Med Singapore 2008, 37:307-314.
54. Nielsen B, Hales JR, Strange S. Human circulatory and thermoregulatory adaptations with heat acclimation and exercise in a hot, dry environment. J Physiol 1993, 460:467-485.
55. Nielsen B, Savard G, Richter EA. Muscle blood flow and metabolism during exercise and heat stress. J Appl Physiol 1990, 69:1040-1046.
56. Nielsen B, Strange S, Christensen NJ. Acute and adaptive responses in human to exercise in a warm, humid environment. Pflügers Arch 1997, 434:49-56.
57. Nybo L, Secher NH. Cerebral perturbations provoked by prolonged exercise. Prog Neurobiol 2004, 72((4)):223-261.
58. Pannier JL, Bouckaert JJ, Lefebvre RA. The antiserotonin agent pizotifen does not increase endurance performance in humans. Eur J Appl Physiol Occup Physiol 1995, 72((1-2)):175-178.
59. Parise G, Bosman MJ, Boecker DR. Selective serotonin reuptake inhibitors: their effect on high-intensity exercise performance. Arch Phys Med Rehabil 2001, 82((7)):867-871.
60. Parkin JM, Carey MF, Zhao S. Effect of ambient temperature on human skeletal muscle metabolism during fatiguing submaximal exercise. J Appl Physiol 1999, 86((3)):902-908.
61. Piacentini MF, Meeusen R, Buyse L. No effect of a noradrenergic reuptake inhibitor on performance in trained cyclists. Med Sci Sports Exerc 2002a, 34((7)):1189-1193.
62. Piacentini MF, Meeusen R, Buyse L. No effect of a selective serotonergic/noradrenergic reuptake inhibitor on endurance performance. Eur J Sport Sci 2002b, 2((6)):1-10.
63. Piacentini MF, Meeusen R, Buyse L. Hormonal responses during prolonged exercise are influenced by a selective DA/NA reuptake inhibitor. Br J Sports Med 2004, 38((2)):129-133.
64. Quan N, Xin L, Blatteis C. Microdialysis of norepinephrine into preoptic area of guinea pigs: characteristics of hypothermic effect. Am J Physiol 1991, 261:R378-R385.
65. Quan N, Xin L, Ungar A. Preoptic norepinephrine-induced hypothermia is mediated by alpha 2-adrenoceptors. Am J Physiol 1992, 262:R407-R411.
66. Roelands B, Goekint M, Heyman E. Acute norepinephrine reuptake inhibition decreases in normal and high ambient temperature. J Appl Physiol 2008a, 105((1)):206-212.
67. Roelands B, Hasegawa H, Watson P. Acute DA reuptake inhibition enhances performance in warm but not temperate conditions. Med Sci Sports Exerc 2008b, 40((5)):879-858.
68. Roelands B, Goekint M, Buyse L. Time trial performance in normal and high ambient temperature: is there a role for 5-HT? Eur J Appl Physiol 2009a, 107((1)):119-126.
69. Roelands B, Hasegawa H, Watson P. Performance and thermoregulatory effects of chronic bupropion administration in the heat. Eur J Appl Physiol 2009b, 105((3)):493-498.
70. Roelands B, Meeusen R. Alterations in central fatigue by pharmacological manipulations of neurotransmitters in normal and high ambient temperature. Sports Med 2010, 40((3)):223-246.
71. Romanowski W, Grabiec S. The role of serotonin in the mechanism of central fatigue. Acta Physiol Pol 1974, 25((2)):127-134.
72. Rowell LB, Bruce HJ, Conn RD. Reductions in cardiac output, central blood volume and stroke volume with thermal stress in normal men during exercise. J Clin Invest 1966, 45:1801-1816.
73. Rusyniak DE, Zaretskaia MV, Zaretsky DV. 3,4-Methylenedioxy-methamphetamine- and 8-hydroxy-2-di-npropylamino-tetralin-induced hypothermia: role and location of 5-hydroxytryptamine 1A receptors. J Pharmacol Exp Ther 2007, 323:477-487.
74. Schüle C, Baghai T, Schmidbauer S. Reboxetine acutely stimulates cortisol, ACTH, growth hormone and prolactin secretion in healthy male subjects. Psychoneuroendocrinology 2004, 29:185-200.
75. Scott IM, Boulant JA. Dopamine effects on thermosensitive neurons in hypothalamic tissue slices. Brain Res 1984, 306:157-163.
76. Shephard RJ. Is it time to retire the "Central Governor"? Sports Med 2009, 39((9)):709-721.
77. St Clair Gibson A, Baden DA, Lambert MI. The conscious perception of the sensation of fatigue. Sports Med 2003, 33((3)):167-176.
78. St Clair Gibson A, Lambert EV, Rauch LH. The role of information processing between the brain and peripheral physiological systems in pacing and perception of effort. Sports Med 2006, 36((8)):705-722.
79. Strachan AT, Leiper JB, Maughan RJ. The failure of acute paroxetine administration to influence human exercise capacity, RPE or hormone responses during prolonged exercise in a warm environment. Exp Physiol 2004, 89((6)):657-664.
80. Strachan AT, Leiper JB, Maughan RJ. Serotonin2C receptor blockade and thermoregulation during exercise in the heat. Med Sci Sports Exerc 2005, 37((3)):389-394.
81. Struder HK, Hollmann W, Platen P. Influence of paroxetine, branched-chain amino acids and tyrosine on neuroendocrine system responses and fatigue in humans. Horm Metab Res 1998, 30((4)):188-194.
82. Struder HK, Weicker H. Physiology and pathophysiology of the serotonergic system and its implications on mental and physical performance. Part II. Int J Sports Med 2001, 22:482-197.
83. Szabadi E, Bradshaw C, Boston PF. The human pharmacology of reboxetine. Human Psychopharmacol 1998, 13:S3-S12.
84. Szabo S, Blier P. Functional and pharmacological characterization of the modulatory role of serotonin on the firing activity of locus coeruleus norepinephrine neurons. Brain Res 2001, 922:9-20.
85. Taylor JL, Todd G, Gandevia SC. Evidence for a supraspinal contribution to human muscle fatigue. Clin Exp Pharmacol Physiol 2006, 33:400-405.
86. Tucker R, Rauch L, Harley YX. Impaired exercise performance in the heat is associated with an anticipatory reduction in skeletal muscle recruitment. Pflugers Arch 2004, 448((4)):422-430.
87. Walters TJ, Ryan KL, Tate LM, Mason PA. Exercise in the heat is limited by a critical internal temperature. J Appl Physiol 2000, 89((2)):799-806.
88. Watanabe T, Morimoto A, Murakami N. Effect of amine on temperature-responsive neuron in slice preparation of rat brain stem. Am J Physiol 1986, 250:R553-R559.
89. Watson P, Hasegawa H, Roelands B. Acute dopamine/noradrenaline reuptake inhibition enhances human exercise performance in warm, but not temperate conditions. J Physiol 2005, 565((Part 3)):873-883.
90. Wilson WM, Maughan RJ. Evidence for a possible role of 5-hydroxytryptamine in the genesis of fatigue in man: administration of paroxetine, a 5-HT re-uptake inhibitor, reduces the capacity to perform prolonged exercise. Exp Physiol 1992, 77((6)):921-924.
91. Wyndham CH, Rogers GG, Benade AJ, Strydom NB. Physiological effects of the amphetamines during exercise. S Afr Med J 1971, 45((10)):247-252.
92. Zifa E, Fillion G. 5-hydroxytriptamine receptors. Pharmacol Rev 1992, 44((3)):402-440.